PE20010853A1 - ANALGESIC COMPOSITIONS CONTAINING BUPRENORPHINE IN COMBINATION WITH NALOXONE, NALTREXONE, NALMEFEN - Google Patents

ANALGESIC COMPOSITIONS CONTAINING BUPRENORPHINE IN COMBINATION WITH NALOXONE, NALTREXONE, NALMEFEN

Info

Publication number
PE20010853A1
PE20010853A1 PE2000001228A PE0012282000A PE20010853A1 PE 20010853 A1 PE20010853 A1 PE 20010853A1 PE 2000001228 A PE2000001228 A PE 2000001228A PE 0012282000 A PE0012282000 A PE 0012282000A PE 20010853 A1 PE20010853 A1 PE 20010853A1
Authority
PE
Peru
Prior art keywords
nalmefen
naltrexone
naloxone
combination
compositions containing
Prior art date
Application number
PE2000001228A
Other languages
Spanish (es)
Inventor
Christopher Bourne Chapleo
Nicolas Calvert Varey
Keith Mccormack
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of PE20010853A1 publication Critical patent/PE20010853A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UNA COMPOSICION ANALGESIA PARENTERAL O SUBLINGUAL QUE COMPRENDE BUPRENORFINA (N-CICLOPROPILMETIL-7O-[1-(S)-HIDROXI-1,2,2-TRIMETILPROPIL]6,14-ENDOETANO-6,7,8,14-TETRAHIDRO-NORORIPAVINA); UTILIZANDOSE DE 15µg A 200µg Y i)NALOXONA (1-N-ALIL-14-HIDROXINORHIDROMORFINONA) EN UNA RELACION DE PESO DE 12,5 A 1 Y 27,5 A 1; ii)NALTREXONA (1-N-CICLOPROPILMETIL-14-HIDROXINORDIHIDRICO); iii)NALMEFEN (5O)-17-(CICLOPROPILMETIL)-4,5-EPOXI-6-METILEN-MORFINAN-3,14-DIOL) EN UNA RELACION DE PESO DE 12,5 Y 22,5 A 1; CARACTERIZADA PORQUE LA ACCION ANALGESICA DE BUPRENORFINA SE VE POTENCIADA POR LA DOSIS DE NALOXONA, NALTREXONA, NALMEFEN POR LO QUE PUEDE SER UTIL PARA EL TRATAMIENTO DEL DOLORREFERS TO A PARENTERAL OR SUBLINGUAL ANALGESIA COMPOSITION THAT INCLUDES BUPRENORPHINE (N-CYCLOPROPYLMETHYL-7O- [1- (S) -HYDROXY-1,2,2-TRIMETHYLPROPYL] 6,14-ENDOETHANE-6,7,8,14- TETRAHYDRO-NORORIPAVINE); USING FROM 15µg TO 200µg AND i) NALOXONE (1-N-ALYL-14-HYDROXINORHYDROMORPHINONE) IN A WEIGHT RATIO OF 12.5 TO 1 AND 27.5 TO 1; ii) NALTREXONE (1-N-CYCLOPROPYLMEthyl-14-HYDROXINORDIHYDRICO); iii) NALMEFEN (5O) -17- (CYCLOPROPYLMETIL) -4,5-EPOXY-6-METHYLEN-MORPHINAN-3,14-DIOL) IN A WEIGHT RATIO OF 12.5 AND 22.5 TO 1; CHARACTERIZED BECAUSE THE ANALGESIC ACTION OF BUPRENORPHINE IS ENHANCED BY THE DOSE OF NALOXONE, NALTREXONE, NALMEFEN SO IT MAY BE USEFUL FOR THE TREATMENT OF PAIN

PE2000001228A 1999-11-19 2000-11-16 ANALGESIC COMPOSITIONS CONTAINING BUPRENORPHINE IN COMBINATION WITH NALOXONE, NALTREXONE, NALMEFEN PE20010853A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9927359.1A GB9927359D0 (en) 1999-11-19 1999-11-19 Improvements in or relating to organic compositions
US17620800P 2000-01-14 2000-01-14

Publications (1)

Publication Number Publication Date
PE20010853A1 true PE20010853A1 (en) 2001-08-31

Family

ID=10864788

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001228A PE20010853A1 (en) 1999-11-19 2000-11-16 ANALGESIC COMPOSITIONS CONTAINING BUPRENORPHINE IN COMBINATION WITH NALOXONE, NALTREXONE, NALMEFEN

Country Status (3)

Country Link
GB (1) GB9927359D0 (en)
PE (1) PE20010853A1 (en)
ZA (1) ZA200203902B (en)

Also Published As

Publication number Publication date
GB9927359D0 (en) 2000-01-19
ZA200203902B (en) 2003-06-10

Similar Documents

Publication Publication Date Title
GEP20053614B (en) Compositions for Oral Administration Containing Opioid Agonist
ES2241055T3 (en) COMPOSITION CONTAINING AN ANTIBONVULSIONANT TO TREAT NEUROPATHIC PAIN.
TR200400653T4 (en) Pharmaceutical compositions.
IL159766A0 (en) A sustained release oral dosage form of a hydromorphone
AU2643288A (en) Pharmaceutical compositions
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
BG102668A (en) Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x
WO2002036573A3 (en) 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
ME00527B (en) Opioid agonist/antagonist combinations
KR870006891A (en) Oral hygiene composition
DK0845989T3 (en) Pain relieving drug composition
EP0566709A4 (en)
BR9813826A (en) Potential for abusive use of oral administration of analgesic opioids
KR930005617A (en) Compositions and uses thereof containing tramadol and codeine, oxycodone or hydrocodone
IL142921A0 (en) USES FOR Eph RECEPTOR ANTAGONISTS AND AGONISTS TO TREAT VASCULAR DISORDERS
AU7331094A (en) A3 adenosine receptor agonists
BG103047A (en) Granulate for the preparation of quick decomposition and quick dissolving compositions having high medicamentous form content
HUP9800938A2 (en) Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome
TR199802769T2 (en) Topical composition containing a combination of terpenoid compounds and antihistamine compounds.
ES2196337T3 (en) DUALFRICA COMPOSITION OF DUAL COMPONENT FOR DENTAL FLUORATION.
PE123899A1 (en) FORMULATION CONTAINING AN OPIOID IN COMBINATION WITH AN ALPHA-ADRENERGIC AGONIST AND ITS USE AS AN ANALGESIC
KR900007424A (en) Method of using N-acetylglucosamine as a cytoprotective agent and composition thereof
SE8201202L (en) ANTI-INFLAMMATORY ANALGETIC CATAPLASM
ATE255895T1 (en) COMPOSITION FOR PAIN REDUCEMENT CONTAINING A NON-NARKOTIC ALANGESIC AND AN ANALGESIC ENTERTAINER
PE20010853A1 (en) ANALGESIC COMPOSITIONS CONTAINING BUPRENORPHINE IN COMBINATION WITH NALOXONE, NALTREXONE, NALMEFEN

Legal Events

Date Code Title Description
FC Refusal